What Are the Challenges of Implementing Pharmacogenomics in Cancer Care?
Despite its promise, several challenges hinder the widespread adoption of pharmacogenomics in cancer care:
Cost: Pharmacogenomic testing and subsequent personalized treatments can be expensive and are not always covered by insurance. Complexity: The interaction between genes and drugs is complex and not fully understood, making it difficult to predict responses accurately. Ethical and Privacy Issues: Genetic testing raises concerns about privacy and the potential misuse of genetic information. Limited Availability: Access to pharmacogenomic testing and specialized care is limited in some regions, particularly in low-resource settings.
